Journal
JOURNAL OF NEUROVIROLOGY
Volume 26, Issue 4, Pages 602-604Publisher
SPRINGER
DOI: 10.1007/s13365-020-00869-6
Keywords
Intracranial hemorrhage; COVID-19; Anticoagulation
Categories
Ask authors/readers for more resources
SARS-CoV2 has led to a global pandemic affecting almost 3 million people in almost over 3 months. Various clinical presentations have been reported so far and no definite therapy is established. Anticoagulation is recommended by several experts to address the potential prothrombotic complications from COVID-19, but its safety and regimen need further clinical trials and safety and efficacy profile. Here, we present three cases of intracranial hemorrhage in three critically ill patients with COVID-19 and discuss their course in relation to various regimens of anticoagulation used.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available